The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients
ConditionAcute Bronchitis
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age6-11
SponsorSamA Pharmaceutical Co., Ltd
About this trial
Clinical Study to Evaluate the Efficacy and Safety of Atock Dry Syrup with Acute bronchial Patients
Eligibility criteria
Qualifiers
Children aged ≥6 months to <12 years old
Total Bronchitis Severity Scale excluding sputum(BSSEs) ≥4
Wheezing score ≥2
Subjects who present symptoms of Acute Bronchitis within 48 hours from screening visit
Disqualifiers
Subjects with chronic respiratory diseases (e.g., asthma, COPD) or severe respiratory diseases (e.g., pneumonia, cystic fibrosis, influenza, active tuberculosis)
Subjects under treatment with corticosteroids, antibiotics medications
Subjects with severe hepatic and renal impairment
Subjects with a history of drug abuse
Trial design
Treatments tested in this trial
- Atock Dry Syrup with placebo patch
- Tulobuterol patch with placebo dry syrup
Treatment groups
296 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov